US Broker Ratings

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Exploring a Promising 18% Upside in Biotech

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) stands out in the biotech industry with a promising blend of innovative therapeutics and robust market potential. Headquartered in Newark, California, this healthcare sector player..

QuidelOrtho Corporation (QDEL) Stock Analysis: Navigating a 50% Upside Potential Amidst Industry Challenges

QuidelOrtho Corporation (QDEL), a prominent player in the healthcare sector specializing in medical devices, has been capturing investor attention with its intriguing market dynamics and significant upside potential. With its..

SpringWorks Therapeutics, Inc. (SWTX) Stock Analysis: Navigating the Biotech Landscape with a $3.54 Billion Market Cap

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) stands out in the biotechnology sector with its focus on developing treatments for rare diseases and cancers. The company, headquartered in Stamford, Connecticut, has carved..

Metsera, Inc. (MTSR) Stock Analysis: Analysts Predict a 67% Upside for This Biotech Innovator

Metsera, Inc. (NASDAQ: MTSR) is capturing the attention of investors with its impressive potential upside, as analysts project a 67.19% increase from its current trading price of $35.29. This clinical-stage..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Unpacking the 228% Potential Upside

Viking Therapeutics, Inc. (NASDAQ: VKTX) is capturing the attention of investors with its promising potential upside of 228.20%, according to recent analyst ratings. As a biotech company headquartered in San..

Apellis Pharmaceuticals (APLS) Investor Outlook: Analyzing the 39.85% Potential Upside

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) stands out as a compelling opportunity in the biotechnology sector, offering a notable potential upside of 39.85% according to analyst ratings. As a commercial-stage biopharmaceutical..

Ultragenyx Pharmaceutical Inc. (RARE): Analyst Ratings Signal 187% Potential Upside for Investors

Ultragenyx Pharmaceutical Inc. (RARE), a trailblazer in the biotechnology sector, is focused on addressing rare and ultra-rare genetic diseases through its innovative biopharmaceutical solutions. Headquartered in Novato, California, this company..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Navigating a 17.88% Potential Upside in the Dental Solutions Market

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, is capturing investor attention with a notable 17.88% potential upside...

Acadia Healthcare Company, Inc. (ACHC) Stock Analysis: A 32.53% Upside Potential Amidst Robust Buy Ratings

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) stands out in the healthcare sector as a prominent provider of behavioral healthcare services across the United States and Puerto Rico. With a market..

Veracyte, Inc. (VCYT) Stock Analysis: Exploring a 31% Potential Upside in the Diagnostics Sector

Veracyte, Inc. (NASDAQ: VCYT) is a noteworthy player within the healthcare sector, specializing in the diagnostics and research industry. With a market capitalization of $2.39 billion, this California-based company is..

Zai Lab Limited (ZLAB) Stock Analysis: Exploring a 70% Potential Upside in the Biotech Sector

Zai Lab Limited (NASDAQ: ZLAB), a prominent player in the biotechnology sector, is drawing significant attention from investors, thanks to its robust pipeline and exciting market potential. With a market..

Scholar Rock Holding Corporation (SRRK) Investor Outlook: A 53% Potential Upside in Biotech

Scholar Rock Holding Corporation (NASDAQ: SRRK) presents a compelling opportunity for investors interested in the biotechnology sector. With its focus on developing innovative treatments for serious diseases, Scholar Rock has..

Privia Health Group, Inc. (PRVA) Stock Analysis: A Promising 30.86% Upside in the Healthcare Sector

Privia Health Group, Inc. (NASDAQ: PRVA) is making waves within the healthcare sector as a key player in health information services. With a market capitalization of $2.83 billion, this Arlington,..

Arcellx, Inc. (ACLX) Investor Outlook: High Buy Ratings and Significant Upside Potential

Arcellx, Inc. (NASDAQ: ACLX) is rapidly emerging as a notable player in the biotechnology sector, particularly known for its pioneering work in developing immunotherapies for cancer and other challenging diseases...

Merus N.V. (MRUS) Stock Analysis: 37% Upside Potential with Strong Buy Consensus

Merus N.V. (NASDAQ: MRUS) is gaining attention in the biotechnology sector, not just for its innovative bispecific antibody therapeutics but also for its promising stock performance and potential upside. Listed..

Haemonetics Corporation (HAE) Stock Analysis: Exploring a 44% Potential Upside in the Medical Device Sector

Haemonetics Corporation (NYSE: HAE), a prominent player in the healthcare sector, is carving a niche within the medical devices industry. With a market capitalization of $2.63 billion, this Boston-based company..

Warby Parker Inc. (WRBY) Stock Analysis: Navigating Growth with a Forward P/E of 51.72

Warby Parker Inc. (NYSE: WRBY), a notable player in the healthcare sector, particularly in the medical instruments and supplies industry, continues to draw investor interest with its innovative approach to..

Perrigo Company plc (PRGO) Stock Analysis: Unpacking a 44% Potential Upside in the Healthcare Sector

Perrigo Company plc (PRGO), a healthcare stalwart based in Ireland, is capturing investor attention with its intriguing valuation metrics and a significant 44.27% potential upside according to analyst targets. As..

Surgery Partners, Inc. (SGRY) Investor Outlook: Analyzing a 36.62% Potential Upside in the Healthcare Sector

Surgery Partners, Inc. (NASDAQ: SGRY), a significant player in the healthcare industry, operates a robust network of surgical facilities across the United States. As investors seek opportunities in the medical..

PROCEPT BioRobotics (PRCT) Stock Analysis: A Promising 64.85% Upside Potential for the Surgical Robotics Leader

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is carving a significant niche in the healthcare sector with its innovative approach to urological solutions. As a pivotal player in the medical devices industry,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds